首页> 外文会议>American College of Veterinary Internal Medicine Forum Conference >Possible Role of Procalcitonin as Inflammatory Biomarker in Bovine andEquine Species
【24h】

Possible Role of Procalcitonin as Inflammatory Biomarker in Bovine andEquine Species

机译:ProCalcitonin作为牛粪生物标志物的可能作用

获取原文

摘要

During the course of evolution, the immune system has eventually developed to deal with infectious pathogen invasions by various host defense mechanisms. Inflammatory response is one of the primary responses to a microbial invasion, which leads to thesystemic illness which is referred to as sepsis.1 Since the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference in 1991, the term sepsis has been defined as the 'systemic inflammatory response to infection.'2 Theexpression 'systemic inflammatory response syndrome' (SIRS) describes a clinical condition that represents the culmination of the activation of a complex network of acute endogenous mediators of sepsis from endothelial cells, monocytes, macrophages neutrophils and plasma cell precursors, which lead to uncontrolled and widespread inflammation.3 Clinical symptoms of sepsis include tachycardia, tachypnea, fever, leukocytosis, etc. Usually, severe sepsis is accompanied with hypoperfusion or dysfunction of at least one organ. Sepsis associated with multiple organ dysfunction syndrome (MODS) or hypotension is known as septic shock.4 Despite decades of scientific researching, sepsis still represents a huge sanitary and economical problem in both human and veterinary medicine.5-5 Moreover, considering global trends of increasing antimicrobial resistance in both Gram-positive and Gram-negative organisms, much effort has been directed toward identification of biomarkers that are useful in the differential diagnosis of sepsis and other infectious conditions.5-7 An ideal biomarker needs to be a more rapid diagnostic tool, to be able to discriminate between normal or pathologic process, and to give information about response to a pharmacologic or otherwise therapeutic intervention.
机译:在进化过程中,免疫系统最终开发了各种主体防御机制处理传染病病原侵犯。炎症反应是对微生物入侵的主要反应之一,它导致由美国胸部医师/ 1991年近期护理学院协商会会议的美国胸部医师/社会以来称为脓毒症的系统性疾病。败血症术语已被定义作为“对感染的系统性炎症反应”.Excression的“全身炎症反应综合征”(SIRS)描述了一种临床病症,其表示来自内皮细胞,单核细胞,巨噬细胞中性粒细胞的脓毒症急性内源性介质的复杂网络激活的临床病症和血浆细胞前体,导致不受控制和广泛的炎症.3脓毒症的临床症状包括心动过速,Tachypnea,发烧,白细胞增多等。通常,严重的败血症伴有低灌注或至少一个器官的失血障碍。与多器官功能障碍综合征(MODS)或低血压相关的脓毒症被称为脓毒症休克.4尽管有数十年的科学研究,但败血症仍然是人类和兽药的巨大卫生和经济问题。此外,考虑到全球趋势增加革兰氏阳性和革兰氏阴性生物的抗菌性抗性,致力于鉴定在脓毒症和其他传染病的鉴别诊断中有用的生物标志物.5-7理想的生物标志物需要更快的诊断工具,能够区分正常或病理过程,并提供有关对药理学或其他治疗性干预的反应的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号